VRTX · News · 20260814N

Capital Return Program

VERTEX PHARMACEUTICALS INC / MA · 2026-08-14 · Importance 46 · Surprise 42 · No source text

Vertex completed a US$1.42 billion share repurchase program. The amount exceeds the specified US$100 million revenue materiality threshold. The reported buyback followed a 90-day share-price return of 18.19%, although the price movement itself is not treated as a separate topic.

Key facts

Impact estimates

metricdirectionstageexpectedbasis
cashnegativerealized-5.2%Vertex completed a US$1.42 billion share repurchase program.